Thomas A. Keating
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis 10
- Organic Chemistry top 1%
- Multicomponent Synthesis of Heterocycles 7
- Molecular Medicine top 2%
- Molecular Biology top 5%
- Chemical Synthesis and Analysis 8
- Cancer therapeutics and mechanisms 6
- Biochemical and Structural Characterization 6
- Biochemical and Molecular Research 4
- Biotechnology top 2%
-
- HER2/EGFR in Cancer Research 13
-
- Monoclonal and Polyclonal Antibodies Research 12
- Co-authors
- Robert W. ArmstrongChristopher T. WalshPaul TempestS. David BrownAndrew P. CombsC. Gary MarshallLuis E. N. QuadriDeborah A. Miller
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Thomas A. Keating
53 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Pharmacology 1.2k
- Organic Chemistry 1.9k
- Molecular Medicine 200
- Molecular Biology 2.2k
- Biotechnology 219
Countries citing papers authored by Thomas A. Keating
This map shows the geographic impact of Thomas A. Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Keating more than expected).
Fields of papers citing papers by Thomas A. Keating
This network shows the impact of papers produced by Thomas A. Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Keating. The network helps show where Thomas A. Keating may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas A. Keating, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2020 | 87 | |
| 3 | 2020 | 29 | |
| 4 | 2020 | 39 | |
| 5 | 2019 | 30 | |
| 6 | 2015 | 21 | |
| 7 | 2015 | 88 | |
| 8 | 2014 | 49 | |
| 9 | 2014 | 1 | |
| 10 | 2012 | 24 | |
| 11 | 2011 | 39 | |
| 12 | 2007 | 115 | |
| 13 | 2002 | 189 | |
| 14 | 2002 | 146 | |
| 15 | 2001 | 62 | |
| 16 | 2001 | 230 | |
| 17 | 1999 | 124 | |
| 18 | 1998 | 345 | |
| 19 | 1998 | 43 | |
| 20 | 1996 | 84 |
About Thomas A. Keating
Thomas A. Keating is a scholar working on Pharmacology, Molecular Medicine, Oncology, Endocrinology and Biotechnology, having authored 57 papers that have together received 4.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Microbial Natural Products and Biosynthesis (10 papers), Chemical Synthesis and Analysis (8 papers), Multicomponent Synthesis of Heterocycles (7 papers), Cancer therapeutics and mechanisms (6 papers), Biochemical and Structural Characterization (6 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Pharmacology (1.2k citations), Organic Chemistry (1.9k citations), Molecular Medicine (200 citations), Molecular Biology (2.2k citations) and Biotechnology (219 citations). Thomas A. Keating has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Robert W. Armstrong, Christopher T. Walsh, Paul Tempest, S. David Brown, Andrew P. Combs, C. Gary Marshall, Luis E. N. Quadri, Deborah A. Miller, Jason K. Sello and Robert W. Armstrong. Their work appears in journals such as Biochemistry, Cancer Research, Molecular Pharmaceutics, Journal of the American Chemical Society and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.